Reporting Requirements Under the CTA: What Businesses Need to Know

The Corporate Transparency Act (the “CTA”) marks a significant shift in the U.S. corporate regulatory landscape. Aimed at curbing illicit financial activities, the CTA requires many companies to disclose certain information about the entity itself and each of the entity’s beneficial owners. … Read more about Reporting Requirements Under the CTA: What Businesses Need to Know

New York’s Office of Cannabis Management to Begin Accepting License Applications on October 4, 2023

On Tuesday, New York State’s Cannabis Control Board (“CCB”) voted to approve the Office of Cannabis Management’s (“OCM”) proposed cannabis regulations.[1] With the CCB’s approval, the OCM announced that it will begin accepting applications through for cultivator, processor, distributor, … Read more about New York’s Office of Cannabis Management to Begin Accepting License Applications on October 4, 2023

Marijuana Recommended to be Rescheduled to Schedule III

On August 29, 2023, the Department of Human and Health Services (“HHS”) sent a letter to the Drug Enforcement Administration (“DEA”), recommending that marijuana be rescheduled to Schedule III under the Controlled Substances Act (“CSA”)[1]. The CSA currently lists marijuana as a Schedule I … Read more about Marijuana Recommended to be Rescheduled to Schedule III

California Senate Passes Bill to Decriminalize Psilocybin and Psilocin

On Thursday, the California Senate passed Senate Bill 58 (the “Bill”) which would decriminalize possession and personal use of psilocybin, psilocin, mescaline, and dimethyltryptamine (“DMT”).[1] If passed, those age 21 and older would be allowed to use and/or possess a up to one gram of DMT, one … Read more about California Senate Passes Bill to Decriminalize Psilocybin and Psilocin

What We Know From New York’s Revised Cannabis Regulations

Last week New York’s Office of Cannabis Management (“OCM”) released revised Adult Use Cannabis Regulations (the “Revised Regulations”). The Revised Regulations do not make any major changes, however, the Revised Regulations do clarify the application procedures and some potential limitations on the … Read more about What We Know From New York’s Revised Cannabis Regulations

SENATE BILL 23-290 HAS PASSED THE COLOADO SENATE AND IS HEADING TO THE HOUSE OF REPRESENTATIVES

Colorado voters approved Proposition 122, or the Natural Medicine Health Act (“NMHA”) in November of 2022.[1] The goal was to make “Natural Medicine” (as defined in the NMHA) available to those who could benefit from is use. Natural Medicine under the NMHA includes dimethyltryptamine, ibogaine, … Read more about SENATE BILL 23-290 HAS PASSED THE COLOADO SENATE AND IS HEADING TO THE HOUSE OF REPRESENTATIVES

Proposition 122 Passes in Colorado

This past November, Colorado voters approved the legalization of psilocybin mushrooms for personal and medical use. The Natural Medicine Health Act, commonly referred to as Proposition 122 (“Prop 122”) decriminalized the personal use and possession – for adults 21 and older – of … Read more about Proposition 122 Passes in Colorado